Latest News about MRK
Recent news which mentions MRK
From Benzinga
Centre Piece Of Merck's $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular Trial
October 10, 2022
Tickers
MRK
From Benzinga
Failure Of This Merck Study Is A 'Material Risk' But Analysts Are 'Extremely Bullish'
October 10, 2022
Tickers
MRK
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
From Benzinga
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
October 10, 2022
From Benzinga
3 Great Dividend Stocks to Buy in October
October 08, 2022
From Motley Fool
Large number of U.S. COVID deaths could be prevented if patients would take Pfizer’s Paxlovid, White House coordinator warns
October 07, 2022
From MarketWatch
From Benzinga
Why Guardant Health Topped the Market on Thursday
October 06, 2022
From Motley Fool
Verve's Stock Price Could Continue To Rise Through Clinical Progress - Despite Worries About "DeeperPocketed" Competition
October 06, 2022
From Benzinga
Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Proprietary Off-the-Shelf Immunotherapy For Solid Tumors
October 06, 2022
From Benzinga
AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial
October 05, 2022
From Benzinga
The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It's Very Short
October 03, 2022
From Benzinga
From Benzinga
What This News Means for Merck
October 01, 2022
From Motley Fool
'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company
September 30, 2022
From Benzinga
Vietnam Law May Impact Facebook, Twitter; Amazon Has A Sleep Tracker; India Lures Apple, Dell, HP: Top Financial Media Stories Thursday, Sept. 29
September 29, 2022
From Benzinga
From Benzinga
Bear Market: 2 Safe Stocks to Buy Right Now
September 28, 2022
From Motley Fool
7 Blue-Chip Sleeper Stocks to Buy Before Wall Street Wakes Up
September 28, 2022
From InvestorPlace
Corvus Pharma's Partner Secures China Approval For Early-Stage Mupadolimab Trial For Lung, Head & Neck Cancer
September 27, 2022
From Benzinga
7 Dow Sleeper Stocks to Buy Before Wall Street Wakes Up
September 26, 2022
From InvestorPlace
A Stock's Price "Tells You Almost Nothing"
September 24, 2022
From Motley Fool
From Benzinga
My Take: 4 Strong Growth Stocks to Buy This Week
September 23, 2022
From Motley Fool
Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings
September 23, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.